Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC440345 |
| Upstream (Parents) |
|---|
| (<<) EIF3J → LOC440345 |
| (<<) LOC440248///HERC2P2///HERC2P3 → LOC440345 |
| (<<) SFTPA2 → LOC440345 |
| (<<) SCGB1A1 → LOC440345 |
| (<<) IFNA10 → LOC440345 |
| (<<) ZNF473 → LOC440345 |
| (<<) LRP3 → LOC440345 |
| (<<) FAM169A → LOC440345 |
| Downstream (Children) |
|---|
| LOC440345 → LOC440248///HERC2P2///HERC2P3 (>>) |
| LOC440345 → SFTPA2 (>>) |
| LOC440345 → SCGB1A1 (>>) |
| LOC440345 → SLC34A2 (>>) |
| LOC440345 → C9orf27 (>>) |
| LOC440345 → PTH (>>) |
| LOC440345 → FGF16 (>>) |
| LOC440345 → ADCY8 (>>) |
| LOC440345 → NFKBIL2 (>>) |
| LOC440345 → IFNA10 (>>) |
| LOC440345 → C21orf2 (>>) |
| LOC440345 → PHC3 (>>) |
| LOC440345 → RARA (>>) |
| LOC440345 → S100A13 (>>) |
| LOC440345 → PI15 (>>) |
| LOC440345 → CACNB4 (>>) |
| LOC440345 → FAM169A (>>) |
